LAVAL, QC, Dec. 21, 2018 /CNW Telbec/ - Neptune
Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT)
(TSX: NEPT) is pleased to announce today that it has entered into a
multi-year IP licencing and capsule sale agreement with Lonza (SWX:
LONN), a global leader in the life sciences industry. Thanks to the
agreement, Neptune's customers will benefit from Lonza's
proprietary Licaps® liquid filled hard capsule technology combined
with Neptune's leading extraction and purification capabilities,
and significant capacity for the production of cannabis oil.
With an initial annual capacity of up to 200 million capsules,
this licensing agreement will allow Neptune to set up as
large-scale Licaps® manufacturer in the Canadian cannabis sector.
The Licaps® technology supports differentiated product offerings
through its various delivery systems, colours and branding
possibilities. Furthermore, this is an effective technology for
variable and multiple product formulation runs. The new
manufacturing line will be integrated into Neptune's state of the
art 50,000 square foot cGMP facility in Sherbrooke, Quebec.
"We are thrilled to be working with Lonza, renowned for the
quality of its products, and to bring their highly differentiated
and widely adopted proprietary liquid and speciality encapsulation
technology and know-how to the cannabis and hemp industry in
Canada. Lonza's market
leading capsule technology offers advantages to what is now
commonly available in the Canadian cannabis space. Through
our skilled and dedicated cannabis team we look forward to bringing
those benefits to consumers in the Canadian marketplace," said
Jim Hamilton, President & CEO of
Neptune.
This initiative is consistent with Neptune's strategy to offer
value added, differentiated product forms to the cannabis market.
Construction and installation of the new manufacturing line will
commence immediately and represents an investment of approximately
$2.5 million in IP transfer,
know-how, site infrastructure and manufacturing
equipment.
About Neptune Wellness Solutions Inc.
Neptune is a
health and wellness products company, with more than 50 years of
combined experience in extraction, purification and formulation of
value-added differentiated science-based products. Currently, the
Company develops turnkey nutrition product solutions available in
various unique delivery forms, offers specialty ingredients such as
MaxSimil®, a patented ingredient that enhances the absorption of
lipid-based nutraceuticals, and a variety of other marine and seed
oils. Leveraging its scientific, technological and innovative
expertise, Neptune is preparing to commence production of cannabis
oil products for legal cannabis markets. The Company's head office
is located in Laval, Quebec.
Forward Looking Statements
Statements in this press release that are not statements of
historical or current fact constitute "forward-looking statements"
within the meaning of the U.S. securities laws and Canadian
securities laws. Such forward-looking statements involve known and
unknown risks, uncertainties, and other unknown factors that could
cause the actual results of Neptune to be materially different from
historical results or from any future results expressed or implied
by such forward-looking statements. In addition to statements which
explicitly describe such risks and uncertainties, readers are urged
to consider statements labeled with the terms "believes," "belief,"
"expects," "intends," "anticipates," "will," "should," or "plans"
to be uncertain and forward-looking. Readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date of this press release. Forward-looking
information in this press release includes, but is not limited to,
information or statements about our ability to successfully
develop, produce, supply, promote or generate any revenue from the
sale of any cannabis-based products in the legal cannabis
market.
The forward-looking statements contained in this press
release are expressly qualified in their entirety by this
cautionary statement and the "Cautionary Note Regarding
Forward-Looking Information" section contained in Neptune's latest
Annual Information Form (the "AIF"), which also forms part of
Neptune's latest annual report on Form 40-F, and which is available
on SEDAR at www.sedar.com, on EDGAR at
www.sec.gov/edgar.shtml and on the investor section of
Neptune's website at www.neptunecorp.com. All forward-looking
statements in this press release are made as of the date of this
press release. Neptune does not undertake to update any such
forward-looking statements whether as a result of new information,
future events or otherwise, except as required by law. The
forward-looking statements contained herein are also subject
generally to other risks and uncertainties that are described from
time to time in Neptune public securities filings with the
Securities and Exchange Commission and the Canadian securities
commissions. Additional information about these assumptions and
risks and uncertainties is contained in the AIF under "Risk
Factors".
Neither NASDAQ nor the Toronto Stock Exchange accepts
responsibility for the adequacy or accuracy of this
release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/neptune-to-expand-manufacturing-capability-to-offer-cannabis-oil-capsules-in-canada-300770237.html
SOURCE Neptune Wellness Solutions Inc.